Ensign Peak Advisors, Inc Reata Pharmaceuticals Inc Transaction History

Ensign Peak Advisors, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $653,565 - $869,302	8,250 Added 6.97%	126,625 $12.9 Million
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $1.46 Million - $4.42 Million	47,460 Added 66.93%	118,375 $10.8 Million
Q4 2022 Feb 13, 2023	SELL	$22.15 - $42.11 $159,480 - $303,192	-7,200 Reduced 9.22%	70,915 $2.69 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $298,506 - $561,179	15,379 Added 24.51%	78,115 $1.96 Million
Q2 2022 Aug 12, 2022	BUY	$20.71 - $36.5 $855,509 - $1.51 Million	41,309 Added 192.79%	62,736 $1.91 Million
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $358,109 - $587,941	14,847 Added 225.64%	21,427 $702,000
Q4 2021 Feb 11, 2022	BUY	$25.61 - $110.96 $168,513 - $730,116	6,580 New	6,580 $174,000
Q3 2021 Nov 12, 2021	SELL	$100.0 - $143.02 $1.12 Million - $1.6 Million	-11,218 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$78.27 - $151.29 $700,281 - $1.35 Million	8,947 Added 393.97%	11,218 $1.59 Million
Q4 2020 Feb 12, 2021	SELL	$102.03 - $184.62 $752,165 - $1.36 Million	-7,372 Reduced 76.45%	2,271 $281,000
Q3 2020 Nov 12, 2020	BUY	$93.53 - $163.34 $632,169 - $1.1 Million	6,759 Added 234.36%	9,643 $939,000
Q2 2020 Aug 12, 2020	BUY	$126.3 - $176.56 $70,728 - $98,873	560 Added 24.1%	2,884 $450,000
Q1 2020 May 11, 2020	SELL	$124.16 - $247.74 $85,670 - $170,940	-690 Reduced 22.89%	2,324 $335,000
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $224,753 - $656,810	3,014 New	3,014 $617,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.